Cutaneous neoplasms in renal transplant recipients

European Journal of Dermatology

Volumn 12, Issue 6, 2002, Pages 532-535

  Rubel, Jeffrey Rand ^a   Milford, Edgar Louis ^a   Abdi, Reza ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Basal cell carcinoma; Cutaneous malignancy; Renal transplantation; Squamous cell carcinoma

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

AGE; ALLOGRAFT; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; GENDER; HEREDITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MERKEL CELL TUMOR; REVIEW; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VIRUS INFECTION;

CARCINOMA, BASAL CELL; CARCINOMA, MERKEL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; PROGNOSIS; RISK ASSESSMENT; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0036861001     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Penn I. Post-transplant malignancies. Transplant Prac 1999; 31: 1260-2.
2. Birkeland SA, Storm HH, Lamm LU, Barlow L, Blohme I, Forsberg B, Eklund B, Fjeldborg O, Friedberg M, Frodin L, Glattre E, Halvorsen S, Holm NV, Jakobsen A, Jorgensen HE Ladefoged J, Lindholm T Lundgren G, Pukkala E. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60: 183-9.
3. Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dunn DL. De novo cancer in cyclosporine-treated adult primary renal allagraft recipients. Clin Transplant 1994; 8: 388-95.
4. Brown JH, Hutchison T, Kelly AMT, McGeown MG. Dermatologic lesions in a transplant population. Transplantation 1988; 46(4): 530-2.
5. Hardie IR, Strong RW, Hartley LC, Woodruff PWH, Clunie GJA. Skin cancer in Caucasian rena allograft recipients living in a subtropical climate. Surgery 1980; 87(2): 177-83.
6. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, Siskind V, Van der Woude FJ, Hardie IR. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61(5): 715-21.
7. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986; 122(11): 1288-93.
8. Kinlen L, Doll R, Peto J. The incidence of tumors in human transplant recipients. Transplant Proc 1983; 15(1): 1039-42.
9. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5,356 patients following organ transplantation. Br J Dermatol 2000; 143(3): 513-9.
10. Shuttleworth D, Marks R, Griffin PJA, Salaman JR. Epidermal dysplasia and cyclasporine therapy in renal transplant recipients: A comparison with azathioprine. Br J Dermatol 1989; 120: 551-4.
11. Bauwes Bavinck JN, Vermeer BJ, Van der Woude FJ, Vandenbroucke JP, Schreuder GMT, Thorogood J, Persiin GG, Claas FHJ. Relatian between skin cancer and HLA antigens in renal-transplant recipients. NEJM 1991; 325(12): 843-8.
12. Barr BBB, McLaren K, Smith IW, Benton EC, Bunney MH, Blessing K, Hunter JAA. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989; 1: 124-8.
13. Bouwes Bavinck JN, de Boer A, Vermeer BJ, Hartevelt MM, Van der Woude FJV, Claas FHJ, Wolterbeek R, Vanderbroucke JP. Sunlight, keratotic skin lesions, and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242-9.
14. McLelland J, Rees A, Williams G, Chu T. The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 1988; 46(6): 871-4.
15. Blohme I, Larko O. Premalignant and malignant skin lesions in renal transplant patients. Transplantation 1984; 37(2): 165-7.
16. Sheil AGR, Disney APS, Mathew TH, Livingston BER, Keogh AM. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplant Proc 1997; 29: 825-7.
17. Hartevelt MM, Bouwes Bavinck JN, Kootte AMM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49(3): 506-9.
18. Boyle J, Briggs JD, MacKie RM, Junor BJR, Aitchison TC. Cancer, warts, and sunshine in renal transplant patients. Lancet 1984; 1: 702-5.
19. Naldi L, Fortina AB, Lovati S, Barba A, Gotti E, Tessari G, Schena D, Diociaiuti A, Nanni G, La Parola IL, Masini C, Piaserico S, Peserico A, Cainelli T, Remuzzi G. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70(10): 1479-84.
20. Marshall S, Bordea C, Wojnarowska F, Morris P, Welsh K. p53 codon 72 polymorphism and susceptibility to skin cancer after renal transplantation. Transplantation 2000; 69(5): 994-6.
21. Ramsay HM, Harden PN, Reece S, Smith AG, Strange RC, Fryer AA. Genetic risk factors associated with non-melanoma skin cancer in renal transplant recipients. Br J Dermatol 2000; 143 (suppl. 57): 18.
22. Festenstein H, Garrido F. MHC antigens and malignancy. Nature 1986; 322: 502-3.
23. Dausset J, Colombani J, Hors J. Major histocompatibility complex and cancer, with special reference to human familiar tumors. Cancer Surv 1982; 1: 119-47.
24. Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137(4): 459-63.
25. Caforio ALP, Fortina AB, Piaserico S, Alaibac M, Tona F, Feltrin G, Pompei E, Testolin L, Gambino A, Volta SD, Thiene G, Casarotto D, Peserico A. Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102 (19 suppl. 3): III222-7.
26. Lampros TD, Cobanoglu A, Parker F, Ratkovec R, Norman DJ, Hershberger R. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17(6): 586-91.
27. Roeger LS, Sheil AGR, Disney APS, Mathew TH, Amiss N. Risk factors associated with the development of squamous cell carcinomas in the immunosuppressed renal transplant recipients. Clin Transpl 1992; 6: 202.
28. Penn I, First MR. Merkel's cell carcinoma in organ recipients. Transplantation 1999; 68(11): 1717-21.
29. Regamey N, Tamm M, Wernli M, Witxchi A, Thiel G, Cathomas G, Erb P. Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients. NEJM 1998; 339(19): 1358-63.
30. Antman K, Chang Y. Kaposi's sarcoma. NEJM 2000; 342(14): 1027-38.
31. Milliancourt C, Barete S, Marcelin A, Mouquet C, Dupin N, Frances C, Agut H, Bitker MO, Calvez V. Human Herpesvirus-8 seroconversions after reno transplantation. Transplantation 2001; 72(7): 1319-20.
32. Margolius L, Stein M, Spencer D, Bezwoda WR. Kaposi's sarcoma in renal transplant recipients: Experience at Johannesburg Hospital, 1966-1989. S Afr Med J 1994; 84: 16-7.
33. Montagnino G, Bencini PL, Tarantino A, Caputo R, Ponticelli C. Clinical features and course of Kaposi's sarcoma in kidney transplant patients: Report of 13 cases. Am J Nephrol 1994; 14: 121-6.
34. Lesnoni La Parola I, Masini C, Nanni G, Diociaiuti A, Panocchia N, Cerimele D. Kaposi's sarcoma in renal-transplant recipients: Experience at the Catholic University in Rome, 1988-1996. Dermatology 1997; 194: 229-33.
35. Shepherd FA, Maher E, Cardella C, Cole E, Greig P, Wade JA, Levy G. Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol 1997; 15: 2371-7.
36. Euvrard S, Kanitakis J, Bosshard S, Lebbe C, Garnier J, Touraine J, Claudy A. No recurrence of posttransplantation Kaposi's sarcoma three years after renal transplantation. Transplantation 2002; 73(2): 297-9.
37. McKenna DB, Murphy GM. Skin cancer chemoprophylaxis in renal transplant recipients: 5 Years of experience using low-dose acitretin. Br J Dermatol 1999; 140(4): 656-60.